OFFICIAL PUBLICATION OF

by its subsidiary APPco

Heading the charts

Chris Brooker 01/12/2020

What are the ten most commonly dispensed, and the ten most expensive drugs on the PBS at the moment? A drug used to treat eye conditions such as macular degeneration cost the taxpayer almost $400 million in 2019/2020, newly released data has revealed. Analysis of 2019/20 PBS and RPBS data has shown the most commonly

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Heading the charts

Previous Research Roundup

Next Amcal and Guardian celebrate pharmacy champions

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Research Roundup

Next Amcal and Guardian celebrate pharmacy champions

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.